Biomarkers of vitamin B-12 status in NHANES: A roundtable summary

American Journal of Clinical Nutrition

Volumn 94, Issue 1, 2011, Pages

  Yetley, Elizabeth A ^a   Pfeiffer, Christine M ^b   Phinney, Karen W ^c   Bailey, Regan L ^a   Blackmore, Sheena ^d   Bock, Jay L ^e   Brody, Lawrence C ^f   Carmel, Ralph ^g,h   Curtin, L Randy ⁱ   Durazo Arvizu, Ramón A ^j   Eckfeldt, John H ^k   Green, Ralph ^l   Gregory III, Jesse F ^m   Hoofnagle, Andrew N ⁿ   Jacobsen, Donald W ^o,p   Jacques, Paul F ^q   Lacher, David A ⁱ   Molloy, Anne M ^r   Massaro, Joseph ^s   Mills, James L ^t   Nexo, Ebba ^u   Rader, Jeanne I ^v   Selhub, Jacob ^q   Sempos, Christopher ^a   Shane, Barry ^w   Stabler, Sally ^x   Stover, Patrick ^y   Tamura, Tsunenobu ^z   Tedstone, Alison ^aa   Thorpe, Susan J ^ab   Coates, Paul M ^a   Johnson, Clifford L ⁱ   Picciano, Mary Frances ^a   more..

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^c NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

^d Haematology Department   (United Kingdom)

^e STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^f NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^g NEW YORK METHODIST HOSPITAL   (United States)

^h WEILL CORNELL MEDICAL COLLEGE   (United States)

ⁱ NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^j LOYOLA UNIVERSITY CHICAGO   (United States)

^k UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m UNIVERSITY OF FLORIDA   (United States)

ⁿ UNIVERSITY OF WASHINGTON   (United States)

^o CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p LERNER RESEARCH INSTITUTE   (United States)

^q TUFTS UNIVERSITY   (United States)

^r TRINITY COLLEGE DUBLIN   (Ireland)

^s BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^t EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^u AARHUS UNIVERSITY HOSPITAL   (Denmark)

^v CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^w UNIVERSITY OF CALIFORNIA   (United States)

^x UNIVERSITY OF COLORADO   (United States)

^y Department of Obstetrics Gynecology   (United States)

^z UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^aa Nutrition Science and Delivery   (United Kingdom)

^ab NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYANOCOBALAMIN; HOMOCYSTEINE; METHYLMALONIC ACID;

ADVERSE OUTCOME; ANEMIA; COGNITIVE DEFECT; CONFERENCE PAPER; CYANOCOBALAMIN DEFICIENCY; HUMAN; MONITORING; POPULATION RESEARCH; PUBLIC HEALTH; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; COGNITION DISORDERS; HOMOCYSTEINE; HUMANS; METHYLMALONIC ACID; NUTRITION SURVEYS; PUBLIC HEALTH; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 79959470408     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.111.013243     Document Type: Conference Paper

References (59)

1. Yetley EA, Johnson CL. Folate and vitamin B-12 biomarkers in NHANES: history of their measurement and use. Am J Clin Nutr 2011;94(suppl):332S-31S.
2. Bock JL, Eckfeldt JH. Advances in standardization of laboratory measurement procedures: implications for measuring biomarkers of folate and vitamin B-12 status in NHANES. Am J Clin Nutr 2011;94(suppl):332S-6S.
3. Yetley EA, Pfeiffer CM, Phinney KW, et al. Biomarkers of folate status in NHANES: a roundtable summary. Am J Clin Nutr 2011;94(suppl):303S-12S.
4. Yetley EA, Coates PM, Johnson CL. Overview of a roundtable on NHANES monitoring of biomarkers of folate and vitamin B-12 status: measurement procedure issues. Am J Clin Nutr 2011;94(suppl):297S-392S.
5. Green R, Miller JW. Vitamin B12 deficiency is the dominant nutritional cause of hyperhomocysteinemia in a folic acid-fortified population. Clin Chem Lab Med 2005;43:1048-51. (Pubitemid 41581959)
6. Carmel R, Green R, Jacobsen DW, Rasmussen K, Florea M, Azen C. Serum cobalamin, homocysteine, and methylmalonic acid concentrations in a multiethnic elderly population: ethnic and sex differences in cobalamin and metabolite abnormalities. Am J Clin Nutr 1999;70:904-10. (Pubitemid 29512918)
7. Ganji V, Kafai MR. Demographic, lifestyle, and health characteristics and serum B vitamin status are determinants of plasma total homocysteine concentration in the post-folic acid fortification period, 1999-2004. J Nutr 2009;139:345-52.
8. Nexo E., Hoffmann-Lücke E. Holotranscobalamin, a marker of vitamin B-12 status: analytical aspects and clinical utility. Am J Clin Nutr 2011;94(suppl):359S-65S.
9. Carmel R. Biomarkers of cobalamin (vitamin B-12) status in the epidemiologic setting: a critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin II. Am J Clin Nutr 2011;94(suppl):348S-58S.
10. Carmel R, Sarrai M. Diagnosis and management of clinical and subclinical cobalamin deficiency: advances and controversies. Curr Hematol Rep 2006;5:23-33.
11. 12 deficiency. Arch Intern Med 2001;161:1534-41.
12. Morris MS, Jacques PF, Rosenberg IH, Selhub J. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr 2007;85:193-200. (Pubitemid 46067634)
13. Garrod MG, Green R, Allen LH, et al. Fraction of total plasma vitamin B12 bound to transcobalamin correlates with cognitive function in elderly Latinos with depressive symptoms. Clin Chem 2008;54:1210-7. (Pubitemid 352013526)
14. Riggs KM, Spiro A III, Tucker K, Rush D. Relations of vitamin B-12, vitamin B-6, folate and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr 1996;63:306-14. (Pubitemid 26074688)
15. Selhub J, Morris MS, Jacques PF, Rosenberg IH. Folate-vitamin B-12 interaction in relation to cognitive impairment, anemia, and biochemical indicators of vitamin B-12 deficiency. Am J Clin Nutr 2009;89:702S-6S.
16. Miller JW, Garrod MG, Allen LH, Haan MN, Green R. Metabolic evidence of vitamin B-12 deficiency, including high homocysteine and methylmalonic acid and low holotranscobalamin, is more pronounced in older adults with elevated plasma folate. Am J Clin Nutr 2009;90:1586-92.
17. Clarke R, Sherliker P, Hin H, et al. Folate and vitamin B12 status in relation to cognitive impairment and anaemia in the setting of voluntary fortification in the UK. Br J Nutr 2008;100:1054-9.
18. 12 status and for monitoring the efficacy of intervention strategies. Food Nutr Bull 2008;29:S52-63.
19. 12 status. Clin Chem 2009;55:2198-206.
20. Hvas A-M, Nexo E. Holotranscobalamin - a first choice assay for diagnosing early vitamin B deficiency? J Intern Med 2005;257:289-98.
21. 12, holotranscobalamin. Clin Chem 2007;53:963-70.
22. Selhub J, Jacques PF, Rosenberg IH, et al. Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med 1999;131:331-9.
23. Morris MS, Jacques PF, Rosenberg IH, Selhub J. Elevated serum methylmalonic acid concentrations are common among elderly Americans. J Nutr 2002;132:2799-803. (Pubitemid 35013273)
24. Gunter EW, Lewis BG, Koncikowski SM. Laboratory procedures used for the third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. Atlanta, GA: Centers for Disease Control and Prevention; Hyattsville, MD: National Center for Health Statistics, 1996. Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes3/cdrom/nchs/manuals/labman.pdf (cited 4 December 2010).
25. Centers for Disease Control and Prevention. NHANES 1999-2000: folate/vitamin B12, serum and whole blood, Bio-Rad Laboratories' "Quantaphase II folate/vitamin B12" radioassay kit. Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes-99-00/lab06-met-folate-b12.pdf (cited 4 December 2010).
26. Centers for Disease Control and Prevention. NHANES 2001-2002: folate/vitamin B12, serum and whole blood, Bio-Rad Laboratories "Quantaphase II Folate/Vitamin B12" radioassay kit. Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes-01-02/l06-b-met-folate-b12.pdf (cited 4 December 2010).
27. Centers for Disease Control and Prevention. NHANES 2003-2004: folate/vitamin B12, serum and whole blood, Bio-Rad Laboratories' "Quantaphase II Folate/Vitamin B12" Radioassay Kit. Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes-03-04/l06-c-met-folates%20B12.pdf (cited 4 December 2010).
28. Centers for Disease Control and Prevention. NHANES 2005-2006: folate/vitamin B12, serum and whole blood, Laboratories "Quantaphase II Folate/Vitamin B12" radioassay kit. Available from: http://www.cdc.gov/ nchs/data/nhanes/nhanes-05-06/folate-b12-d-met.pdf (cited 4 December 2010).
29. Pfeiffer CM, Johnson CL, Jain RB, et al. Trends in blood folate and vitamin B-12 concentrations in the United States, 1988-2004. Am J Clin Nutr 2007;86:718-27.
30. National Institute of Standards and Technology. Development of standard reference materials for vitamins B6 and B12 in human serum. Available from: http://www.nist.gov/mml/analytical/organic/vitsb6andb12inserum.cfm (cited 4 December 2010).
31. Centers for Disease Control and Prevention. NHANES 1999-2000: methylmalonic acid (MMA), serum, GC/MS. Available from: http://www.cdc.gov/nchs/ data/nhanes/nhanes-99-00/lab06-met-methylmalonic-acid.pdf (cited 4 December 2010).
32. Centers for Disease Control and Prevention. NHANES 2001-2002: methylmalonic acid (MMA), plasma or serum, GC/MS. Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes-01-02/l06-b-met-methylmalonic-acid. pdf (cited 4 December 2010).
33. Centers for Disease Control and Prevention. NHANES 2003-2004: methylmalonic acid (MMA), plasma or serum, GC/MS. Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes-03-04/l06-c-met-mma.pdf (cited 4 December 2010).
34. Pfeiffer CM, Gunter EW. Automated assay for methylmalonic acid (MMA) in plasma. 51st Annual Meeting of American Association of Clinical Chemists, New Orleans, LA, July 1999. Clin Chem 1999;45(suppl 6):A166 (abstr. 593).
35. Blom HJ, Rooij AV, Hogeveen M. A simple high-throughput method for the determination of plasma methylmalonic acid by liquid chromatography-tandem mass spectrometry. Clin Chem Lab Med 2007;45:645-50. (Pubitemid 46709740)
36. Lakso H-A, Appelblad P, Schneede J. Quantification of methylmalonic acid in human plasma with hydrophilic interaction liquid chromatography separation and mass spectrometric detection. Clin Chem 2008;54:2028-35. (Pubitemid 352774036)
37. Fasching C, Singh J. Quantitation of methylmalonic acid in plasma using liquid chromatography-tandem mass spectrometry. Methods Mol Biol 2010;603:371-8.
38. Centers for Disease Control and Prevention. NHANES 1999-2000: total homocysteine (tHcy), plasma, Abbott homocysteine (HCY) assay. Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes-99-00/lab06-met-homocysteine.pdf (cited 4 December 2010).
39. Centers for Disease Control and Prevention. NHANES 2001-2002: total homocysteine (tHcy), plasma, "Abbott AxSYM homocysteine (HCY) assay." Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes-01-02/l06-b-met- homocysteine-Axsym.pdf (cited 4 December 2010).
40. Centers for Disease Control and Prevention. NHANES 2001-2002: total homocysteine (tHcy), plasma, Abbott IMX homocysteine (HCY) assay. Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes-01-02/l06-b-met-homocysteine- IMX.pdf (cited 4 December 2010).
41. Centers for Disease Control and Prevention. NHANES 2003-2004: total homocysteine (tHcy), plasma, Abbot homocysteine (HCY) assay. Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes-03-04/l06-c-met-homocysteine.pdf (cited 4 December 2010).
42. Centers for Disease Control and Prevention. NHANES 2005-2006: total homocysteine (tHcy), plasma, "Abbott Homocysteine (HCY) assay." Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes-05-06/hcy-d-met.pdf (cited 4 December 2010).
43. Pfeiffer CM, Twite D, Shih J, Holets-McCormack SR, Gunter EW. Method comparison for total plasma homocysteine between the Abbott IMx analyzer and an HPLC assay with internal standardization. Clin Chem 1999;45:152-3. (Pubitemid 29036407)
44. Pfeiffer CM, Caudill SP, Gunter EW, et al. Analysis of factors influencing the comparison of homocysteine values between the third National Health and Nutrition Examination Survey (NHANES) and NHANES 1999+. J Nutr 2000;130:2850-4.
45. Pfeiffer CM, Osterloh JD, Kennedy-Stephenson J, et al. Trends in circulating concentrations of total homocysteine among US adolescents and adults: findings from the 1991-1994 and 1999-2004 National Health and Nutrition Examination Surveys. Clin Chem 2008;54:801-13.
46. Brady J, Wilson L, McGregor L, Valente E, Orning L. Active B12: a rapid, automated assay for holotranscobalamin on the Abbott Ax- SYM analyzer. Clin Chem 2008;54:567-73. (Pubitemid 351348161)
47. Morkbak AL, Heimdal RM, Emmens K, et al. Evaluation of the technical performance of novel holotranscobalamin (holoTC) assays in a multicenter European demonstration project. Clin Chem Lab Med 2005;43:1058-64. (Pubitemid 41581961)
48. National Institute of Standards and Technology. Certificate of analysis, standard reference material 1955, homocysteine and folate in frozen human serum. April 2008. Available from: https://www-s.nist.gov/srmors/certificates/1955. pdf?cfid=1126897&cftoken=ad62a5219ffb884e-41496e79- a2d7-bed2- 991ce742a98a0716&jsessionid=f030a960d9d22f92f6db3a34674d5a634a2a (cited 4 December 2010).
49. National Institute of Standards and Technology. Certificate of analysis, standard reference material 909b, human serum. November 2003. Available from: http://ts.nist.gov/measurementservices/referencematerials/archived-certificates/ 909b.Nov19.2003.pdf (cited 4 December 2010).
50. National Institute of Standards and Technology. Development of a standard reference material for metabolites in plasma. Available from: http://www.nist.gov/mml/analytical/organic/metabolitesinserum.cfm (cited 4 December 2010).
51. Satterfield MB, Sniegoski LT, Welch MJ, Nelson BC. Comparison of isotope dilution mass spectrometry methods for the determination of total homocysteine in plasma and serum. Anal Chem 2003;75:4631-8. (Pubitemid 37082257)
52. Satterfield MB, Sniegoski LT, Sharpless KE, et al. Development of a new standard reference material: SRM 1955 (homocysteine and folate in human serum). Anal Bioanal Chem 2006;385:612-22.
53. Nelson BC, Pfeiffer CM, Sniegoski LT, Satterfield MB. Development and evaluation of an isotope dilution LC/MS method for the determination of total homocysteine in human plasma. Anal Chem 2003;75:775-84. (Pubitemid 36232429)
54. Nelson BC, Pfeiffer CM, Zhang M, Duewer DL, Sharpless KE, Lippa KA. Commutability of NIST SRM 1955 homocysteine and folate in frozen human serum with selected total homocysteine immunoassays and enzymatic assays. Clin Chim Acta 2008;395:99-105.
55. JCTLM/Joint Committee on Traceability in Laboratory Medicine. Isotope dilution mass spectrometry methods for homocysteine in blood serum. Sèvres Cedex, France: Bureau International des Poids et Mesures. Available from: http://www.bipm.org/jctlm/search.do?sortBy=Analyte- Name&searchString=homocysteine&analyteCategory=& matrixCategory=&countryCode=&status=P&type=isRMP&x=38&y=4 (cited 4 December 2010).
56. Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ. Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr 2005;82:442-50.
57. Valuck RJ, Ruscin JM. A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults. J Clin Epidemiol 2004;57:422-8. (Pubitemid 38609284)
58. Howden CW. Vitamin B12 levels during prolonged treatment with proton pump inhibitors. J Clin Gastroenterol 2000;30:29-33. (Pubitemid 30032651)
59. Clarke R, Birks J, Nexo E, et al. Low vitamin B-12 status and risk of cognitive decline in older adults. Am J Clin Nutr 2007;86:1384-91. (Pubitemid 350126242)